Opioid-specific risk of respiratory depression in non-cancer pain: a retrospective cohort study - Takeaways - MDSpire

Opioid-specific risk of respiratory depression in non-cancer pain: a retrospective cohort study

  • By

  • Carlos Raul Ramirez Medina

  • Mark Lunt

  • William G. Dixon

  • Meghna Jani

  • July 8, 2026

  • 0 min

Share

  • 1

    The study investigates respiratory depression risk from opioids in non-cancer pain patients using electronic health records.

  • 2

    Incidence rates of respiratory depression vary widely, ranging from 0.04% to 46%, depending on the definitions and proxies used.

  • 3

    Concomitant use of benzodiazepines and gabapentinoids significantly increases the risk of opioid-related respiratory depression.

  • 4

    The study excludes patients with cancer or those receiving opioids for anaesthetic purposes to focus on non-cancer pain.

  • 5

    Data on opioid administration is derived from electronic prescribing records, ensuring accurate exposure assessment.

Original Source(s)

Opioid-specific risk of respiratory depression in non-cancer pain: a retrospective cohort study

  • by Carlos Raul Ramirez Medina, Mark Lunt, William G. Dixon, Meghna Jani

  • July 8, 2026

Related Content

Transforming surgical ward rounds: constructivist pedagogy, structured models, and intelligent technologies

A two-phase machine learning framework for coronary heart disease risk prediction: Integrating population ecology with individual pathophysiology

Diagnostic utility of the insulin-to-C-peptide molar ratio in differentiating insulin autoimmune syndrome and exogenous insulin antibody syndrome from insulinoma